Novozymes OneHealth cultivates global probiotic market to help develop industry of page 2 | investinchina.chinaservicesinfo.com

Novozymes OneHealth cultivates global probiotic market to help develop industry

chinadaily.com.cn Updated: May 29, 2023
The booth of Novozymes OneHealth at the 2023 China Gut Conference in Beijing. [Photo provided to chinadaily.com.cn]

The main businesses of OneHealth are currently gastrointestinal health, brain health, immune health, metabolism and oral health. In the development of probiotic products, OneHealth has bacterial strain products including Lactobacillus reuteri DSM17648, Bifidobacterium longum 35624 and Bifidobacterium longum 1714.

CONTACT US

Reach out to us for information on how we can facilitate your investment journey

* Please leave a message
* Your Email Address
SUBMIT
Copyright©2024 China Daily. All rights reserved.

Novozymes OneHealth cultivates global probiotic market to help develop industry

chinadaily.com.cn Updated: May 29, 2023
The booth of Novozymes OneHealth at the 2023 China Gut Conference in Beijing. [Photo provided to chinadaily.com.cn]

The main businesses of OneHealth are currently gastrointestinal health, brain health, immune health, metabolism and oral health. In the development of probiotic products, OneHealth has bacterial strain products including Lactobacillus reuteri DSM17648, Bifidobacterium longum 35624 and Bifidobacterium longum 1714.

Invest in China Copyright © 2024 China Daily All rights Reserved
京ICP备13028878号-6

京公网安备 11010502032503号